By Indu Tyagi Ketan, 28 November, 2022
On November 22nd, IFF (International Flavors & Fragrances Inc.) stated that it had formed a strategic relationship with Salus Optima, a customized nutrition, health, and wellness firm with a British basis, to enter the personalized nutrition market more quickly. The alliance will first concentrate on metabolic health, which affects more than 25% of adults worldwide and includes obesity, pre-diabetes, high cholesterol, and pre-hypertension. The businesses are creating wearable technology and a smartphone app that will enable users to analyze their metabolic response to meals, supplements, movement, and sleep. Brand owners now have access for the first time to a ready-to-brand customized nutrition digital platform that is already filled with branded foods, drinks, and supplements that target metabolic health.
The following advantages for brand owners will arise from this platform. The technology provides brand owners with a product marketing tool that captures rich, first-party data outside of traditional points of sale to help brands serve customers more effectively by understanding their needs. Simple consumer setup and integration with wearables and mobile devices result in actionable, engaging, customized recommendations to accomplish health and wellness objectives. It has been demonstrated that Salus Optima Technology, which offers cutting-edge behavior modification strategies, may enhance brand lifetime value by as much as double digits by encouraging, inspiring, and enabling customers to reach their wellness and health goals.
At IFF, a leader in the food, beverage, health, biosciences, and sensory experiences industries, science and creativity come together to produce life-changing inventions and experiences, from well-known landmarks to surprising discoveries. A leading innovation partner for clients in a wide range of consumer goods, industrial, and agricultural industries, IFF's Health & Biosciences business is characterized by its world-class bioscience and microbiome expertise. IFF’s Health & Biosciences sector collaborates closely with clients to improve goods and processes to provide safer, healthier, and more environmentally friendly solutions.
Salus Optima is one of the global leaders in individualized nutrition and personalized health technologies. Digital products from Salus Optima provide advice for comprehensive human performance for a healthy way of life at work and in leisure. Years of R&D went into developing the fundamental technology that addresses the issues individuals encounter daily. Salus Optima empowers individuals by giving them more control over their health and well-being by making the most cutting-edge scientific approaches available to the general public.
Indu Tyagi Ketan
Chief Strategy Officer
Accenture and Coca-Cola Bottlers Japan joined in a new venture in August 2023. The new collaboration will initiate in January 2024 to help Coca-Cola Bottlers Japan Group's goal to set itself as a data-driven firm having back-office operations and…
The world's largest oil producer, Saudi Aramco, has released the results from the second quarter and half year of 2023. The gains have dropped by 30 percent in the initial six months of 2023. The prices of crude oil have declined due to geopolitical…
The Semiconductor Industry Association (SIA) in the United States has released a statement to set up new rules and actions for the outbound investment screening in August 2023. The US has targeted China, with developments coming further on releasing…
Accenture announced to invest USD 3 billion in artificial intelligence (AI) practices in 2023 to provide new industry solutions and previously built models that will provide companies across nineteen industries to drive value and accelerate clients.
…